Trademark: 98174937
Word
CLOAKLINK
Status
Pending
Status Code
688
Status Date
Tuesday, August 13, 2024
Serial Number
98174937
Mark Type
4
Filing Date
Tuesday, September 12, 2023
Published for Opposition
Tuesday, June 18, 2024
Trademark Owner History
Solve Therapeutics, Inc. - Owner At Publication
Classifications
5 chemical products for medicinal and pharmaceutical use, namely, monoclonal-antibody-drug-conjugate preparations for the treatment of cancer or other indicated human disease; pharmaceutical products for the treatment of cancer, autoimmune diseases, and viral infections; preparations for the medical treatment of cancer consisting of a monoclonal antibody (mAb) or antibody fragment connected to an anti-cancer payload or toxin or immune-stimulant via a chemical linker; chemical reagents for medical use
Trademark Events
Sep 15, 2023
New Application Entered
May 10, 2024
Approved For Pub - Principal Register
May 29, 2024
Notification Of Notice Of Publication E-Mailed
Jun 18, 2024
Published For Opposition
Jun 18, 2024
Official Gazette Publication Confirmation E-Mailed
Aug 13, 2024
Noa E-Mailed - Sou Required From Applicant
Oct 2, 2023
New Application Office Supplied Data Entered
May 7, 2024
Assigned To Examiner
BLAST TRACK
WOCONWOR
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov